| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |